Running title: IgG Fc glycosylation changes with age and sex 2 ABSTRACT Age-and sex-dependence of subclass specific immunoglobulin G (IgG) Fc N-glycosylation was evaluated for 1709 individuals from two isolated human populations. IgGs were obtained from plasma by affinity purification using 96-well protein G monolithic plates and digested with trypsin. Fc N-glycopeptides were purified and analyzed by negative-mode MALDI-TOF-MS with 4-chloro-α-cyanocinnamic acid (Cl-CCA) matrix. Age-associated glycosylation changes were more pronounced in younger individuals (<57 years) than in older individuals (>57 years) and in females than in males. Galactosylation and sialylation decreased with increasing age and showed significant sex dependence. Interestingly, the most prominent drop in the levels of galactosylated and sialylated glycoforms in females was observed around the age of 45 to 60 years when females usually enter the menopause. The incidence of bisecting N-acetylglucosamine increased in younger individuals and reached a plateau at older age. Furthermore, we compared the results to the total IgG N-glycosylation of the same populations recently analyzed by hydrophilic interaction liquid chromatography (HILIC). Significant differences were observed in the levels of galactosylation, bisecting Nacetylglucosamine and particularly sialylation which were shown to be higher in HILIC analysis. Age-and sex-association of glycosylation features was to a large extent comparable between MALDI-TOF-MS and HILIC IgG glycosylation profiling.
INTRODUCTION
Immunoglobulin G (IgG) is the most abundant glycoprotein in human serum and a major effector molecule of the humoral immune response. Human IgG occurs in four subclasses (IgG1-4), and each molecule consists of two heavy and two light chains. The two light chains together with the parts of the heavy chains (VH and CH1 domains) form two Fab (fragment antigen-binding) moieties which are linked by a flexible hinge region to one Fc (fragment crystallizable) moiety formed by the remainders of the two heavy chains (CH2 and CH3 domains). 1 Each heavy chain in the Fc region carries a single covalently attached biantennary N-glycan at the highly conserved asparagine 297. 2 Fc glycans are essential structural components of the IgG molecule and minor changes in glycan composition can significantly alter the conformation of the Fc region changing the interaction with receptor proteins and thus modulating the effector functions of IgG. 3, 4 The lack of core fucose enhances the IgG1 binding to activating Fc receptor FcγRIIIa leading to increased antibody dependent cellular cytotoxicity (ADCC) and destruction of target cells. 2, [5] [6] [7] . Moreover, the presence of sialic acid on the Fc N-glycans confers anti-inflammatory properties to IgG. 8 In a mouse arthritis model the anti-inflammatory effect of sialylated IgG was shown to be mediated through interaction with SIGN-R1, a lectin receptor on mouse splenic macrophages, the human orthologue of this receptor being DC-SIGN. 9, 10 Very recently Karsten et al. 11 reported anti-inflammatory properties to be mediated by Fc galactosylation via the formation of immune complexes.
High N-glycan galactosylation of IgG1 in immune complexes was shown to promote the association between the inhibitory IgG receptor FcγRIIB and C-type lectin-like receptor dectin-1, resulting in a blockage of pro-inflammatory effector functions. 11 Following numerous reports on the importance of IgG Fc N-glycosylation for effector functions, 4 engineering the Fc region of therapeutic antibodies has become a major challenge and goal for the biopharmaceutical industry. 3 The majority of IgG N-glycans are attached to heavy chains of the Fc region, but 15-20% of polyclonal human IgG molecules also contain glycans within the Fab regions which were found to be more highly bisected, galactosylated and sialylated than Fc glycans. 3, [12] [13] [14] [15] Microheterogeneity of human IgG glycans is known to be dependent on various physiological (age, sex, pregnancy) and pathological parameters (tumors, infections, autoimmune diseases, etc.). 1 A number of earlier studies have reported that specific patterns of IgG glycosylation change with age and depend on gender. Parekh et al. were the first to describe decreasing levels of galactosylation with aging. 16 Subsequently, it has been shown that agedependent galactosylation levels are sex-specific and that levels of bisected glycoforms change with age as well. [17] [18] [19] Moreover, in a recent large-scale study of IgG glycans decreased levels of agalactosylated glycoforms with bisecting N-acetylglucosamine (GlcNAc) were found to be an early marker of familial longevity. 19 In this study, we performed large-scale IgG1 and IgG2&3 Fc N-glycosylation profiling by negative-mode MALDI-TOF-MS with 4-chloro-α-cyanocinnamic acid (Cl-CCA) matrix in 1709 individuals and investigated age-and sex-specificity of the glycosylation features: sialylation, galactosylation, fucosylation, and the occurrence of bisecting GlcNAc. We compare the results to the total IgG glycosylation recently analyzed by hydrophilic interaction liquid chromatography (HILIC) of enzymatically released and fluorescently labeled glycans. 20 
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EXPERIMENTAL SECTION Study population. The study was based on plasma samples from respondents who were residents of the Croatian Adriatic islands, Vis and Korčula, and who were recruited within a larger genetic epidemiology program previously described. 21, 22 In total, 1709 individuals were included with 795 subjects from Vis (46.5%) and 914 (53.5%) from Korčula. The age range was 18-98 years (median age 57, interquartile range 21 years). There were 61.7% IgG purification. Immunoglobulin G was isolated from plasma by affinity chromatography using 96-well protein G monolithic plates as previously reported. 20 Briefly, 50 µl of plasma was diluted 10x with PBS, applied to the protein G plate and instantly washed. IgGs were eluted using 1000 µl of 100 mM formic acid and immediately neutralized to pH 7.0 with 1 M ammonium bicarbonate.
Trypsin digestion of human polyclonal IgG. Aliquots (1/20; 50 µl) of the protein G eluates were brought to 96-well polypropylene V-bottom microtitration plates, and a standard IgG sample was added in six-fold to each plate to allow evaluation of inter-batch variation. TPCK trypsin (Sigma-Aldrich, St. Louis, MO) was first dissolved in ice-cold 20 mM acetic acid (Merck, Darmstadt, Germany) to a final concentration of 0.4 µg/µl after which it was further diluted to 0.02 µg/µl with ice-cold ultra-pure water. For overnight digestion at 37°C, 20 µl of diluted trypsin was added to each IgG sample. 6 Reverse-phase solid phase extraction (RP-SPE) of glycopeptides. Glycopeptides were purified and desalted by reverse phase (RP) solid phase extraction (SPE) using Chromabond C18ec beads (Marcherey-Nagel, Düren, Germany) as described previously. 23 Briefly, C-18 beads were activated with 80% ACN containing 0.1% trifluoroacetic acid (TFA; Fluka) and conditioned with 0.1% TFA. Tryptic IgG digests were diluted with 0.1% TFA, loaded onto C-18 beads and washed with 0.1% TFA. IgG glycopeptides were eluted with low concentration of ACN (18%) containing 0.1% TFA to minimize coelution of interfering peptides. Eluates were dried by vacuum centrifugation and stored at -20°C until mass spectrometric analysis. The heating and acid steps of the sample preparation method were evaluated and found not to lead to any noticeable degradation of the Fc glycan moieties with regard to sialylation and fucosylation.
MALDI-TOF-MS of IgG glycopeptides.
Large-scale IgG glycosylation analysis was performed using MALDI-TOF-MS. Samples were dissolved in 20 μl of water, and 3 μl aliquots were spotted onto MTP 384 polished steel target plates (Bruker Daltonics, Bremen, Germany) and allowed to dry at room temperature. Subsequently 1 µL of 5 mg/mL 4-chloro-αcyanocinnamic acid (Cl-CCA; 95% purity; Bionet Research, Camelford, Cornwall, UK) in 50 % acetonitrile was applied on top of each sample and allowed to dry. 24, 25 Glycopeptides were analyzed on an UltrafleX II MALDI-TOF/TOF mass spectrometer (Bruker Daltonics) which was operated in the negative-ion reflectron mode. Ions between m/z 1000 and 3800 were recorded. To allow homogeneous spot sampling a random walk laser movement with 50 laser shots per raster spot was applied and each IgG glycopeptide sum mass spectrum was generated by accumulation of 2000 laser shots. Mass spectra were internally calibrated using a list of known glycopeptides. Data processing and evaluation were performed with FlexAnalysis Software (Bruker Daltonics) and Microsoft Excel, respectively. The data were 7 baseline subtracted and the intensities of a defined set of 27 glycopeptides (16 glycoforms for IgG1 and 11 for IgG2&3) were automatically defined for each spectrum (Table 1) . IgG2 and IgG3 have identical peptide moieties (E293EQFNSTFR301) of their tryptic Fc glycopeptides and are, therefore, not distinguished by the profiling method. 23 Relative intensities of IgG Fc glycopeptides were obtained by integrating and summing four isotopic peaks followed by normalization to the total subclass specific glycopeptide
intensities. An exception was made for the IgG1 G1S1 (monogalactosylated, monosialylated biantennary glycan without core fucose, see Table 1 ) glycoform for which only the first isotopic peak could be reliably determined as the 2 nd , 3 rd and 4 th isotopic peaks overlap with peaks of the IgG4 G2F glycoform and thus cannot be used to calculate the sum intensity.
Instead, the signal intensity for the sum of four isotopic peaks of the IgG1 G1S1 glycoform was determined by multiplying the signal of the 1 st isotopic peak of the IgG1 G1S1 glycoform with a correction factor (4.348, which is the average ratio of the sum of all four isotopic peaks versus the 1 st isotopic peak determined for the related G2S1 glycoform of 126 standard samples).The level of galactosylation was calculated from the relative intensities of various Fc N-glycoforms (Table  1) according to the formula:
(G1+G1F+G1FN+G1N+G1S1+G1FS1)*0.5+G2+G2F+G2FN+G2N+G2S1+G2FS1 for the IgG1 subclass and (G1F+G1FN+G1S1+G1FS1)*0.5+G2F+G2FN+G2FS1 for the IgG2&3 subclasses.
The prevalence of bisecting GlcNAc was determined by summing the relative intensities of all bisected glycoforms (G0N, G1N, G2N, G0FN, G1FN, and G2FN for IgG1 and G0N, G0FN, G1FN, and G2FN for IgG2&3). The level of sialylation was defined by summation of all sialylated glycoforms (G1S1, G1FS1, G2S1, and G2FS1 for IgG1 and G1S1, G1FS1, and G2FS1 for the IgG2&3 subclasses). The incidence of IgG1 fucosylation was evaluated by summing all fucosylated IgG1 Fc N-glycoforms (G0F+G0FN+G1F+G1FN+G1FS1+G2F+G2FN+G2FS1 peaks. Therefore, these two subclasses were determined together. IgG4 Fc N-glycopeptides were not determined due to the low abundance of their signals and overlap with other signals (Table 1) . 26 Mass spectra were processed automatically which resulted in the determination of 16 IgG1 Fc glycoforms and 11 IgG2&3 Fc glycoforms ( Table 1 and Figure 1 ). Glycoforms were assigned on the basis of their composition and literature data on human plasma IgG glycosylation. 13, 20, 27 Relative intensities of glycoforms were obtained by integration and summation of four isotopic peaks followed by normalization to the total subclass specific glycopeptide intensities.
Comparison of MALDI
To determine inter-and intra-batch variation of the analytical method, a standard IgG sample was added in six replicates to each sample plate. The intra-batch and inter-batch variation were determined for the five major glycoforms of the standard IgG samples, and the relative standard deviation (RSD) was found to be ≤ 6% for each sample plate (intrabatch) and below 10% over the entire 20 plates (inter-batch) for both IgG1 and IgG2&3. No batch correction was performed.
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Association of IgG glycosylation with age and sex. We evaluated the correlation of IgG glycosylation features and glycoforms with age ( Table 2 ). The obtained data showed a pronounced decrease of IgG1 and IgG2&3 Fc galactosylation with age. The relative abundances of agalactosylated IgG glycoforms (represented by G0F glycoform) increased at higher age (Supplementary Figure 1A and D). The opposite was observed for glycoforms with one or two galactoses (represented by G1F and G2F, respectively) which abundances decreased with age (Supplementary Figure 1B , C, E and F). Previously, it has been shown that IgG glycosylation changes with age are sex-specific and that those associations are more evident and stronger in individuals of up to 50-60 years of age. 18, 19, 28 Therefore, to reveal more details we divided our whole population into two age groups at median age (57 years of age). Younger individuals, both female and male, showed stronger negative correlation between age and galactosylation in all tested IgG subclasses. Stronger correlation coefficients in the younger group were also observed in all of the rest of glycosylation features, independent of the sex and subclass ( Table 2) . Statistically significant differences (p ≤0.001) between the two age groups were revealed for all the glycosylation features that showed significant age dependence (Table 3) .
When galactosylation was evaluated for the entire age range no sex difference was revealed (data not shown). However, by analyzing the data stratified for ages below and above the median age statistically significant differences in IgG galactosylation between females and males emerge. Younger females showed a stronger correlation between galactosylation and age than males for both IgG1 and IgG2&3 ( Table 2 ). The level of galactosylation reached similar values for both sexes around median age after which sex differences in galactosylation changes with age were less obvious (Figure 2A and D). Interestingly, while the younger group of females (age ≤57) appeared to have higher galactosylation than males 12 (median of 43.0% versus 39.0%, respectively), at older age this relationship seemed to be reversed with males showing higher level of galactosylation than females (median of 33.9% versus 31.3%, respectively; Table 3 ).
Association of IgG sialylation with age showed a trend similar to that of galactosylation. The level of sialylated glycoforms significantly decreased with increasing age for both IgG1 and IgG2&3 ( Table 2 ). This negative correlation was more pronounced for younger individuals than for older ones. Correlation of age with sialylation was stronger in females than in males.
Moreover, just like in the case of galactosylation, IgG sialylation for younger individuals was higher in females than in males ( Figure 2C and F). Around the age of 60 sialylation reached similar levels for both sexes after which males exhibited higher level of sialylation.
The incidence of bisecting GlcNAc increased with age ( Table 2 ; Figure 2B and E). However, significant positive correlations were observed only for the younger individuals, while in the older age group the abundance of bisecting GlcNAc-containing glycoforms seemed to reach a plateau ( Figure 2B and E). Within both age groups, no sex differences were found except for the IgG2&3 subclasses which showed higher level of bisecting GlcNAc in older females compared to males of similar age.
In addition, age-and sex-dependent variations in IgG1 core fucosylation were evaluated. A weak but nevertheless significant negative age effect on the level of IgG1 core fucosylation was observed only in younger individuals ( Table 2) . Within our cohort, there was no clear difference in fucosylated IgG1 glycoforms between females and males (Table 3 ).
Next, we analyzed correlations between different IgG glycosylation features with Spearman's rank test (Table 4 ). The strongest relationship was found between galactosylation and the level of sialylation for IgG1 (r = 0.68) as well as IgG2&3 (r = 0.84) ( Figure 3A and C). IgG1 galactosylation showed a negative correlation (r = -0.17) with the level of core fucosylation 13 ( Supplementary Figure 2A ). An even stronger negative correlation was observed between IgG1 sialylation and core fucosylation, r = -0.38 ( Figure 3B ). Over the whole age range the galactosylation of the analyzed IgG subclasses exhibited a weak negative (r = -0.09 for IgG1
and r = -0.11 for IgG2&3) but significant correlation with the incidence of bisecting GlcNAc (Supplementary Figure 2D , E and F). Interestingly, this effect showed a pronounced agedependence for the IgG1 subclass: while younger individuals revealed a negative correlation (r = -0.12), at higher age galactosylation appeared to positively correlate (r = 0.13) with bisecting GlcNAc. We additionally observed a negative correlation (r = -0.30) between the level of core fucosylated IgG1 N-glycans and the incidence of bisecting GlcNAc ( Figure 3D ). In addition, a weak positive correlation (r = 0.13) was observed between the bisecting GlcNAc and sialylated IgG1 N-glycans (Supplementary Figure 2B) . A similar positive correlation (r = 0.16) was observed for bisecting GlcNAc and sialylation of IgG2&3 subclasses but only for older individuals (Supplementary Figure 2C ). Figure 3 ). The strongest correlation was observed for the 14 galactosylation of neutral glycoforms of total IgG and subclass-specific Fc glycopeptides (r ≥0.90). The degree of sialylation of total fucosylated glycoforms as well as the levels of bisecting GlcNAc in neutral glycoforms analyzed by the two methods also revealed a positive correlation but with weaker coefficients (r ≥0.51 and r ≥0.70, respectively).
Comparison of MALDI-TOF-MS and HILIC
Next, MALDI-TOF-MS and HILIC data were compared with respect to age-and sexdependence. Very similar differences regarding sex and age groups were consistently observed for IgG1
Fc, IgG2&3 Fc, and the total IgG (Supplementary Table 2 ). Significant differences between younger and older females were observed for the levels of galactosylation, bisecting GlcNAc and the degree of sialylation. In males, only the galactosylation levels measured by both methods notably differed between the two age groups (below and above age 57). As for the bisecting GlcNAc, the difference between younger and older males was revealed only for IgG1 Fc, while IgG2&3 Fc and the total IgG showed a difference in the degree of sialylation. 15 Regardless of the analytical method, older individuals showed sex differences in all glycosylation features, with the exception of bisecting GlcNAc of IgG1. Similarly, younger females and males had significantly different levels of galactosylation and sialylation. Median levels of glycosylation features for the whole studied population were compared between the total IgG and subclass-specific Fc fragments (Supplementary Table 2 ). Levels of galactosylation and bisecting GlcNAc as well as the degree of sialylation were higher for the total IgG than for the IgG Fc glycosylation data sets ( Figure 4) . The difference was most prominent in the degree of sialylation of fucosylated glycoforms since the total IgG exhibited approximately 7 times higher level of sialylation than IgG1 Fc and IgG2&3 Fc. For all three data sets the level of galactosylation and the level of sialylation showed the same trend of sex-associated differences in both age groups: while younger females had higher levels of galactosylation and sialylation than males, at older age males showed higher levels of both features than females ( Supplementary Figure 4 ). Another trait for which similar results were obtained in the different data sets is the incidence of the bisecting GlcNAc (Supplementary Table 2 ) which was increasing only in younger individuals and showed no difference between the sexes. At older age (>57 years) no significant change in the incidence of bisecting GlcNAc was observed anymore, but sex differences became apparent for IgG2&3 Fc and total IgG, with females showing higher level of this feature.
In the next analysis step, we looked at the relations between glycosylation features for each of the three data sets and compared these relations between IgG1 Fc, IgG2&3 Fc and total IgG (Supplementary Table 3 ). In all three cases a strong positive correlation between the level of galactosylation and sialylation was noticed (r ≥0.65 for the whole age range).
Negative association (r ≥ -0.17) of the galactosylation and the incidence of the bisecting GlcNAc for the total IgG was observed over the whole age range and in younger individuals 16 following the stratification at median age. Similarly, IgG2&3 Fc showed a negative association, while in the case of IgG1 Fc the only significant correlation was a positive one in older individuals. Correlations of the degree of sialylation and the level of bisecting GlcNAc showed the opposite direction for the Fc fragments and the total IgG. IgG1 Fc and IgG2&3 Fc had a significant positive correlation (r ≥ 0.14) between those two features for the whole age range as well as for the stratified age groups. By contrast, total IgG showed a negative correlation significant for the whole age range (r = -0.19) as well as for the younger group of individuals (r = -0.17).
In addition, to evaluate the observed difference in sialylation between Fc glycopeptides Table 6 ) was even 3x higher than in linear negative mode MS analysis of glycopeptides.
Next, we analyzed the total released glycans of IgG and IgG Fc standards by negative linear mode MALDI-TOF-MS (after 2-AA-labeling; see Supplementary Table 4 for mass list) and
HILIC (after 2-AB-labeling; Supplementary Figure 5 ). The coefficient of variation (CV) between MS and HILIC data for IgG standard of the major sialylated species, G1FS1 and G2FS1, was found to be less than 5%. Less abundant sialylated glycans (<1%), show much higher CV between two methods (data not shown).
DISCUSSION
We performed a large-scale IgG glycopeptide profiling by MALDI-TOF-MS with Cl-CCA matrix for 1709 individuals from two isolated human populations. In accordance with literature findings, our results showed a clear tendency of decreased galactosylation and sialylation with increasing age. 16-20, 23, 28 In both age groups (above and below the median age of 57 years) we observed sex-related differences with females showing higher levels at young age, In line with the parallel decrease of galactosylation and sialylation we observed, as expected, a strong positive and highly significant correlation between these two features for all the analyzed subclasses. It was reported that GalT-I (β-1,4-galactosyltransferase I) and ST6Gal-I (α-2,6-sialyltransferase I) form a complex which increases their enzymatic activity, suggesting that these two N-glycosyltransferases act cooperatively in N-glycan synthesis. 31 Additionally, we noticed that both galactosylation and sialylation of IgG1 tend to negatively correlate with the level of core fucosylation. IgG galactosylation and fucosylation changes going in different directions have been previously described for juvenile chronic arthritis and rheumatoid arthritis. 32, 33 18 For both sexes and both IgG1 Fc N-glycans and IgG2&3 Fc N-glycans we confirmed an increasing incidence of bisecting GlcNAc with age. [17] [18] [19] [20] 23 In accordance with Yamada et al.
who have reported the level of bisecting GlcNAc reaching a plateau at the age of 50 years 18 we did not detect a correlation between age and bisecting GlcNAc in older individuals.
Addition of a bisecting GlcNAc by GnT-III (β-1,4-N-acetylglucosaminyltransferase III) has been shown to prohibit the subsequent addition of a core fucose. 34 In line with this we found for the IgG1 subclass a significant negative correlation between bisection and fucosylation.
Furthermore, GnT-III has also been reported to negatively affect the addition of galactose by
GalT (β-1,4-galactosyltransferase). 35 In our study, we observed a weak negative correlation between galactosylation and bisection for both IgG1 Fc and IgG2&3 Fc over the whole age range. Interestingly, upon stratification to younger and older groups of individuals, correlation coefficients of almost the same strength but different direction were revealed.
While the younger group followed the direction of the whole age range showing a negative correlation of IgG1 galactosylation and bisection, at older age this correlation appeared to be positive, indicating the occurrence of pronounced changes in the regulation of IgG Fc glycosylation with increasing age.
IgG glycosylation of our cohort was analyzed by hydrophilic interaction chromatography and by MALDI-TOF mass spectrometry. In the first approach, a mixture of released Fab and Fc Nglycans of all four IgG subclasses was analyzed in detail. 20 In the second approach, presented in this paper, we have thoroughly analyzed IgG Fc glycosylation in a subclass-specific manner. Very strong correlation between galactosylation levels determined by HILIC and those determined by MS of glycopeptides unambiguously demonstrates the high quality of
both data sets. One should keep in mind that the very limited scattering of the data is only in 19 part caused by measurement inaccuracies, and may for a large part be caused by the inclusion of Fab glycans in the HILIC but not in the MS analyses.
By comparing glycosylation features measured by both methods, we observed many parallels, next to some striking differences: HILIC analysis of total IgG revealed higher levels of galactosylation and bisection in neutral glycoforms, and sialylation which was on average seven-fold higher for HILIC than for IgG1 Fc and IgG2&3 Fc. Increased levels of these glycosylation features observed in the HILIC analysis may largely be linked to the inclusion of Fab glycans, as Fab glycans are known to show an increased incidence of fully galactosylated, sialylated and bisected structures compared to the Fc. 12, 14, 15, 36 However, the analysis of sialylation levels by mass spectrometry is complicated by two phenomena: first, the charge introduced by the sialic acid will influence ionization. It may be assumed that negative-mode ionization of the sialylated species was more efficient than the ionization of glycopeptides with non-sialylated, neutral glycan chains. Second, sialic acids are known to be labile and will, therefore, be lost to some extent upon MALDI-ionization via in-source decay or metastable decay. 37 Glycan compositions are given in terms of hexose (H), N-acetylhexoamine (N), deoxyhexose (fucose; F), and N-acetylneuraminic acid (sialic acid; S). Structural schemes are given as in Figure 1 . Table 3 . Descriptives of glycosylation features in females and males with statistical significance (P) of sex differences and differences between age groups.
Sex differences found to be significant after Bonferroni correction for age and glycosylation features (P ≤0.006 for IgG1 and P ≤0.008 for IgG2&3), and differences between age groups found to be significant after Bonferroni correction for sex and glycosylation features (P ≤0.006 for igG1 and P ≤0.008 for IgG2&3) are in bold. IQR -interquartile range. Abbreviations of glycosylation features as in Table 2 .
IgG subclass
Glycosylation feature Table 4 . Correlation coefficients (r) of glycosylation features.
Correlations found to be significant after Bonferroni correction (P ≤0.004 for IgG1 and P ≤0.008 for IgG2&3) are in bold. Abbreviations of glycosylation features as in Table 2 .

Glycosylation feature
All ages Ages ≤ 57 Ages > 57
IgG1 Fc
Gal -0.09 (<0.001) G0  G0F  G0N  G1F  G0FN  G2F  G1FN  G1FS1  G2FN  G2FS1   G1  G2  G1N  G1S1  G2N  G2S1 A graphic -a designated figure for Abstract G0  G0F  G0N  G1F  G0FN  G2F  G1FN  G1FS1  G2FN  G2FS1   G1  G2  G1N  G1S1  G2N 
IgG1 Fc Gal_n IgG2&3 Fc Gal_n Total IgG Gal_n IgG1 Fc Bis GlcNAc_n
IgG2&3 Fc Bis GlcNAc_n Total IgG Bis GlcNAc_n
IgG1 Fc FGS/(F+FG+FGS)
IgG2&3 Fc FGS/(F+FG+FGS)
Total IgG FGS/(F+FG+FGS)
Relative abundance (%) Fig. 4 Figure 1 . Age dependence of IgG1 and IgG2 &3 glycoforms with correlation coefficients (r) and coefficients of determination (R 2 ). Intens. Intens. . Glycan species are given as in Table 1 . Glycan species are given as in Table 1. 2-AB-labeled N-glycans were analyzed by HILIC as described in the Experimental section. Nglycopeptides were prepared and analyzed as follows: Positive correlation coefficients (r) for age indicate increased levels with increasing age, while negative correlation coefficients indicate decreased levels with increasing age. Correlations found to be significant after Bonferroni correction for gender and glycosylation features (P≤0.008) are in bold. Gal_n -level of galactosylation in neutral glycoforms, Bis GlcNAc_n -level of bisecting N-acetylglucosamine in neutral glycoforms and FGS/(F+FG+FGS) -degree of sialylation of fucosylated glycoforms without bisecting Nacetylglucosamine. Supplementary Table 2 . Descriptives of glycosylation features in females and males with statistical significance (P) of sex differences and differences between age groups for the IgG1 Fc, IgG2&3 Fc and the total IgG. 19.0 (4.9) <0.001 <0.001 <0.001
Supplementary Figure 1
P-values of sex differences (P≤0.006) and differences between age groups (P≤0.006) found to be significant after Bonferroni correction for multiple comparisons are in bold. IQR -interquartile range. Gal_n -level of galactosylation in neutral glycoforms, Bis GlcNAc_n -level of bisecting N-acetylglucosamine in neutral glycoforms and FGS/(F+FG+FGS) -degree of sialylation of fucosylated glycoforms without bisecting N-acetylglucosamine.
Supplementary Table 3 . Correlation coefficients of glycosylation features for the IgG1 Fc, IgG2&3 Fc and the total IgG. Glycan species are given as in Table 1 . Glycan species are given as in Table 1 . * only IgG1 glycopeptides measured
Supplementary
